Price Chart

Profile

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
URL http://www.designtx.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 10, 2026 (est.)
Last Earnings Release Nov. 05, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.
URL http://www.designtx.com
Investor Relations URL N/A
HQ State/Province California
Sector Health Care
Industry Biotechnology
Next Earnings Release Mar. 10, 2026 (est.)
Last Earnings Release Nov. 05, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A